This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Grosskopf, I. Articles by Blum, I. Search for Related Content PubMed PubMed Citation Articles by Grosskopf, I. Articles by Blum, I. Social Bookmarking                         What's this?

Hyperphosphataemia and Hypocalcaemia Induced by Hypertonic Phosphate Enema - An Experimental Study and Review of the Literature

Department of Internal Medicine 'C', Rokach Hospital

Eran Graff

Biochemical Laboratory, Ichilov Hospital, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel

Gideon Charach

Department of Internal Medicine 'C', Rokach Hospital

Gideon Binyamin

Department of Internal Medicine 'C', Rokach Hospital

Sara Spinrad

Department of Internal Medicine 'C', Rokach Hospital

Ilana Blum

Department of Internal Medicine 'C', Rokach Hospital

1 The study objective was to determine the hyperphosphataemic and hypocalcaemic effect of hypertonic phosphate enema. The study was conducted in a department of Internal Medicine at a University Medical Center.

2 Fourteen patients were studied. Patients' mean age (± s.d.) was 78.5 ± 9 years. The creatinine clearance was 48.2 ± 17.4 ml min^-1 (mean ± s.d.).

3 500 ml (approx. 7 ml kg^-1) of Fleet enema (FE - Na₂HPO₄.7H ₂O 224 mmol l^-1 and NaH₂PO₄.H ₂O 1160 mmol l^-1) were administered to each patient. Blood was drawn before FE administration and , 1, 3, 5, 12 and 24 h thereafter. Serum was analysed for levels of inorganic phosphorus and for calcium.

4 The serum inorganic phosphorus level rose from 1.01 ± 0.3 mmol l^-1 to 1.4 ± 0.5 mmol l^-1 (P = 0.001) 1 h after FE was administered. Serum calcium decreased from 2.32 ± 0.12 mmol l^-1 to 2.12 ± 0.1 mmol l^-1 ( P < 0.001) 12 h after FE was administered.

5 We conclude that FE carries a potential risk for acutely ill elderly patients. To avoid untoward effects due to hyperphosphataemia and hypocalcaemia, the phosphate load must be adjusted to the patient's renal function, i.e. enema volume is to be lowered when phosphate concentration is high, so that if renal function is compromised the amount of phosphate absorbed does not exceed renal excretion capacity.

Human & Experimental Toxicology, Vol. 10, No. 5, 351-355 (1991)
DOI: 10.1177/096032719101000509


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?